- ►diabetesjournals.org RH Knopp, M d'Emden, JG Smilde, SJ Pocock - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—A total of 2,410 subjects with type 2 diabetes were randomized. Mean
LDL cholesterol reduction in the atorvastatin group over 4 years was 29% versus
placebo (P < 0.0001). When we compared atorvastatin versus placebo, ... Cited by 19 - Related articles - All 3 versions
- Free from Publisher RH Knopp - Diabetes Care, 2006 - Am Diabetes Assoc We mention in our article the high rates of treatment “drop in” and “drop
out” and the potential impact on the primary end point (mostly due to changing
guidelines and study design changes). While Gazi and Mikhailidis correctly ... Cited by 100 - Related articles - BL Direct - All 8 versions
[CITATION] for the Treating to New Targets Investigators. Effect of lowering LDL cholesterol …
S Yamada, T Yanagawa, K Sasamoto, A Araki … - Metabolism, 2006 - Elsevier We investigated the meaning and the worth of lowering low-density lipoprotein
cholesterol (LDL-C) to less than 100 mg/dL in Japanese type 2 diabetic patients
using atorvastatin. As a multicenter open-labeled study, 84 type 2 diabetic ... Cited by 8 - Related articles - All 16 versions
DM Riche, KS McClendon - American Journal of Health-System Pharmacy, 2007 - pt.wkhealth.com DANIEL M. RICHE, PHARM.D., BCPS, is Assistant Professor, Department of Pharmacy
Practice, School of Pharmacy; and KATIE S. McCLENDON, PHARM.D., BCPS, is
Clinical Assistant Professor, Department of Pharmacy Practice, School of ... Cited by 4 - Related articles - BL Direct - All 8 versions
- ►ebmonline.org HC Lam, CH Chu, MC Wei, HM Keng, CC Lu, … - Experimental Biology and Medicine, 2006 - SEBM We investigated the effects of three different daily doses (10 mg, 20 mg, and 40
mg) of atorvastatin, a relatively new and potent statin, on plasma endothelin
(ET)-1 and highly sensitive C-reactive protein (CRP) levels in type 2 ... Cited by 11 - Related articles - BL Direct - All 5 versions
